Biblio

Export 791 results:
[ Author(Desc)] Title Type Year
Filters: Keyword is Humans  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
D
B. Downer, Veeranki, S. P., and Wong, R., A Late Life Risk Index for Severe Cognitive Impairment in Mexico., J Alzheimers Dis, vol. 52, no. 1, pp. 191-203, 2016.
B. Dubois, Padovani, A., Scheltens, P., Rossi, A., and Dell'Agnello, G., Timely Diagnosis for Alzheimer's Disease: A Literature Review on Benefits and Challenges., J Alzheimers Dis, vol. 49, no. 3, pp. 617-31, 2016.
B. Dubois, Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. Luis, Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., Cappa, S., Crutch, S., Engelborghs, S., Frisoni, G. B., Fox, N. C., Galasko, D., Habert, M. - O., Jicha, G. A., Nordberg, A., Pasquier, F., Rabinovici, G., Robert, P., Rowe, C., Salloway, S., Sarazin, M., Epelbaum, S., de Souza, L. C., Vellas, B., Visser, P. J., Schneider, L., Stern, Y., Scheltens, P., and Cummings, J. L., Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria., Lancet Neurol, vol. 13, no. 6, pp. 614-29, 2014.
B. N. Dugger, Whiteside, C. M., Maarouf, C. L., Walker, D. G., Beach, T. G., Sue, L. I., Garcia, A., Dunckley, T., Meechoovet, B., Reiman, E. M., and Roher, A. E., The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 2, pp. 345-56, 2016.
J. Dukart, Sambataro, F., and Bertolino, A., Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers., J Alzheimers Dis, vol. 49, no. 4, pp. 1143-59, 2016.
T. Dziedzic, Pera, J., Klimkowicz-Mrowiec, A., Mroczko, B., and Slowik, A., Biochemical and Radiological Markers of Alzheimer's Disease Progression., J Alzheimers Dis, vol. 50, no. 3, pp. 623-44, 2016.
E
M. Edwards, Hall, J., Williams, B., Johnson, L., and O'Bryant, S., Molecular markers of amnestic mild cognitive impairment among Mexican Americans., J Alzheimers Dis, vol. 49, no. 1, pp. 221-8, 2016.
T. Eichler, Thyrian, J. René, Hertel, J., Richter, S., Wucherer, D., Michalowsky, B., Teipel, S., Kilimann, I., Dreier, A., and Hoffmann, W., Unmet Needs of Community-Dwelling Primary Care Patients with Dementia in Germany: Prevalence and Correlates., J Alzheimers Dis, vol. 51, no. 3, pp. 847-55, 2016.
A. Bryndis Einarsdottir, Hardarson, S. Hakon, Kristjansdottir, J. Valgerdur, Bragason, D. Thor, Snaedal, J., and Stefánsson, E., Retinal oximetry imaging in Alzheimer's disease., J Alzheimers Dis, vol. 49, no. 1, pp. 79-83, 2016.
L. L. Ekblad, Toppala, S., Johansson, J. K., Koskinen, S., Sundvall, J., Rinne, J. O., Puukka, P., Viitanen, M., and Jula, A., Albuminuria and Microalbuminuria as Predictors of Cognitive Performance in a General Population: An 11-Year Follow-Up Study., J Alzheimers Dis, vol. 62, no. 2, pp. 635-648, 2018.
S. Eketjäll, Janson, J., Kaspersson, K., Bogstedt, A., Jeppsson, F., Fälting, J., Haeberlein, S. Budd, Kugler, A. R., Alexander, R. C., and Cebers, G., AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics., J Alzheimers Dis, vol. 50, no. 4, pp. 1109-23, 2016.
M. Elahi, Hasan, Z., Motoi, Y., Matsumoto, S. - E., Ishiguro, K., and Hattori, N., Region-Specific Vulnerability to Oxidative Stress, Neuroinflammation, and Tau Hyperphosphorylation in Experimental Diabetes Mellitus Mice., J Alzheimers Dis, vol. 51, no. 4, pp. 1209-24, 2016.
R. Sakshaug Eldholm, Barca, M. Lage, Persson, K., Knapskog, A. - B., Kersten, H., Engedal, K., Selbæk, G., Brækhus, A., Skovlund, E., and Saltvedt, I., Progression of Alzheimer's Disease: A Longitudinal Study in Norwegian Memory Clinics., J Alzheimers Dis, vol. 61, no. 3, pp. 1221-1232, 2018.
O. Elkana, Eisikovits, O. Reichman, Oren, N., Betzale, V., Giladi, N., and Ash, E. L., Sensitivity of Neuropsychological Tests to Identify Cognitive Decline in Highly Educated Elderly Individuals: 12 Months Follow up., J Alzheimers Dis, vol. 49, no. 3, pp. 607-16, 2016.
E. M. Elzayat, Shahien, S. A., El-Sherif, A. A., and Hosney, M., miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer's Disease., J Alzheimers Dis, vol. 94, no. s1, pp. S203-S225, 2023.
S. Emrani, Libon, D. J., Lamar, M., Price, C. C., Jefferson, A. L., Gifford, K. A., Hohman, T. J., Nation, D. A., Delano-Wood, L., Jak, A., Bangen, K. J., Bondi, M. W., Brickman, A. M., Manly, J., Swenson, R., and Au, R., Assessing Working Memory in Mild Cognitive Impairment with Serial Order Recall., J Alzheimers Dis, vol. 61, no. 3, pp. 917-928, 2018.
K. I. Erickson, Voss, M. W., Prakash, R. Shaurya, Basak, C., Szabo, A., Chaddock, L., Kim, J. S., Heo, S., Alves, H., White, S. M., Wojcicki, T. R., Mailey, E., Vieira, V. J., Martin, S. A., Pence, B. D., Woods, J. A., McAuley, E., and Kramer, A. F., Exercise training increases size of hippocampus and improves memory., Proc Natl Acad Sci U S A, vol. 108, no. 7, pp. 3017-22, 2011.
H. Ulugut Erkoyun, van der Lee, S. J., Nijmeijer, B., van Spaendonk, R., Nelissen, A., Scarioni, M., Dijkstra, A., Samancı, B., Gürvit, H., Yıldırım, Z., Tepgeç, F., Bilgic, B., Barkhof, F., Rozemuller, A., van der Flier, W. M., Scheltens, P., Cohn-Hokke, P., and Pijnenburg, Y., The Right Temporal Variant of Frontotemporal Dementia Is Not Genetically Sporadic: A Case Series., J Alzheimers Dis, vol. 79, no. 3, pp. 1195-1201, 2021.
M. Ettcheto, Busquets, O., Cano, A., Sánchez-López, E., Manzine, P. R., Espinosa-Jimenez, T., Verdaguer, E., Sureda, F. X., Olloquequi, J., Castro-Torres, R. D., Auladell, C., Folch, J., Casadesus, G., and Camins, A., Pharmacological Strategies to Improve Dendritic Spines in Alzheimer's Disease., J Alzheimers Dis, vol. 82, no. s1, pp. S91-S107, 2021.
P. Eustache, Nemmi, F., Saint-Aubert, L., Pariente, J., and Péran, P., Multimodal Magnetic Resonance Imaging in Alzheimer's Disease Patients at Prodromal Stage., J Alzheimers Dis, vol. 50, no. 4, pp. 1035-50, 2016.
A. Ezra, Rabinovich-Nikitin, I., Rabinovich-Toidman, P., and Solomon, B., Multifunctional Effect of Human Serum Albumin Reduces Alzheimer's Disease Related Pathologies in the 3xTg Mouse Model., J Alzheimers Dis, vol. 50, no. 1, pp. 175-88, 2016.

Pages